US Patent Issued to Regeneron Pharmaceuticals on March 24 for "Treatment of psoriasis with interferon induced Helicase C domain 1 (IFIH1) inhibitors" (New York Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,584,174, issued on March 24, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Treatment of psoriasis with interferon induced Helicase C domain 1 (IFIH1) inhibitors" was invented by Julie E. Horowitz (Tarrytown, N.Y.), Manuel Allen Revez Ferreira (Tarrytown, N.Y.), Katherine Siminovitch (Tarrytown, N.Y.), Aris Baras (Tarrytown, N.Y.), Lori Khrimian (Tarrytown, N.Y.) and Katia Karalis (Tarrytown, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods of treating subjects having psoriasis, and methods of identifying subjects having an increased risk of developing psoriasis."

The patent was filed on J...